Both in Biotechnology
Surrozen vs Eikon Therapeutics
Over the past year SRZN returned +36.7% and EIKN returned −64.6%; their daily moves had a correlation of 0.21.
SRZN +36.7% EIKN −64.6%Growth of $1, one year, split-adjusted
| Metric | SRZN | EIKN |
|---|---|---|
| Price | $29.04 | $5.31 |
| Market cap | $341.3M | $287.6M |
| Today | −1.43% | −0.75% |
| 1 month | −3.2% | −28.3% |
| 6 months | −13.6% | −45.1% |
| Year to date | +28.5% | — |
| 1 year | +113.7% | — |
| Revenue growth (YoY) | +408.6% | — |
| Gross margin | 100.0% | — |
| Net margin | 640.8% | — |
| P/E (TTM) | — | — |
| Price / sales | 29.7× | — |
| Net cash | $102.0M | $531.2M |
| Dividend yield | — | — |
| Volatility (60d) | 174.0% | 99.4% |
| Short % of float | 37.0% | 20.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).